Therefore, based on the cardioprotective role of GRP78 in vivo, it is reasonable to speculate that the downregulation of GRP78 protein observed in FBXO32 mutant hearts contributes to the cardiomyopathy rather than represents a secondary compensatory effect. This evidence concerns the gene HSPA5 and cardiomyopathy.